Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 07 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has announced that it received a Notice of Compliance from Health Canada for ZDS-Varenicline tablets in two dosages, marking its first approval in Canada. The tablets are intended to assist with smoking cessation and will be manufactured at Zydus's facility in Ahmedabad.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases